Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review-Reference-Cited by-同舟云学术

Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review

Published:2021-03-25 Issue: Volume: Page:
ISSN:1382-4147
Container-title:Heart Failure Reviews
language:en
Short-container-title:Heart Fail Rev

Author:

Goyal Amandeep^ORCID,Lahan Shubham^ORCID,Dalia Tarun^ORCID,Ranka Sagar^ORCID,Bhattad Venugopal Brijmohan,Patel Ronak R.,Shah Zubair^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10741-021-10098-6.pdf

Reference21 articles.

1. Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337(13):898–909. https://doi.org/10.1056/NEJM199709253371306

2. Kelly JW, Colon W, Lai Z, Lashuel HA, McCulloch J, McCutchen SL, Miroy GJ, Peterson SA (1997) Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem 50:161–181. https://doi.org/10.1016/s0065-3233(08)60321-6

3. Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73(22):2872–2891. https://doi.org/10.1016/j.jacc.2019.04.003

4. Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, Judge DP, Lenihan DJ, Gottlieb SS, Shah SJ, Steidley DE, Ventura H, Murali S, Silver MA, Jacoby D, Fedson S, Hummel SL, Kristen AV, Damy T, Plante-Bordeneuve V, Coelho T, Mundayat R, Suhr OB, Waddington Cruz M, Rapezzi C, Investigators T (2016) Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol 68(2):161–172. https://doi.org/10.1016/j.jacc.2016.03.596

5. Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL, Plante-Bordeneuve V, Schmidt HHJ, Merlini G (2015) Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol 66(21):2451–2466. https://doi.org/10.1016/j.jacc.2015.09.075

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular insights into A97S variants in hereditary transthyretin amyloid polyneuropathy in South China;Amyloid;2024-07-31

2. Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review;Journal of Comparative Effectiveness Research;2024-07

3. Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis;The American Journal of Cardiology;2024-04

4. Pathophysiology, Classification, and Epidemiology of Amyloidosis;Cardiac Amyloidosis;2024

5. Black Women and Transthyretin Amyloidosis;JACC: Heart Failure;2023-09